<VariationArchive VariationID="930112" VariationName="NM_001904.4(CTNNB1):c.807del (p.Met271fs)" VariationType="Deletion" Accession="VCV000930112" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2020-07-04" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="918237" VariationID="930112">
      <GeneList>
        <Gene Symbol="CTNNB1" FullName="catenin beta 1" GeneID="1499" HGNC_ID="HGNC:2514" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="41199505" stop="41240443" display_start="41199505" display_stop="41240443" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="41240941" stop="41281938" display_start="41240941" display_stop="41281938" Strand="+" />
          </Location>
          <OMIM>116806</OMIM>
          <Haploinsufficiency last_evaluated="2017-11-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CTNNB1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-11-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CTNNB1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001904.4(CTNNB1):c.807del (p.Met271fs)</Name>
      <CanonicalSPDI>NC_000003.12:41225731:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="41225732" stop="41225732" display_start="41225732" display_stop="41225732" variantLength="1" positionVCF="41225731" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="41267223" stop="41267223" display_start="41267223" display_stop="41267223" variantLength="1" positionVCF="41267222" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>NM_001904.4(CTNNB1):c.807del</Name>
        <Name>p.Met271fs</Name>
      </OtherNameList>
      <ProteinChange>M264fs</ProteinChange>
      <ProteinChange>M271fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.41267223del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.41267223del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.41225732del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.41225732del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013302.2" sequenceAccession="NG_013302" sequenceVersion="2" change="g.31282del">
            <Expression>NG_013302.2:g.31282del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001098209.2" sequenceAccession="NM_001098209" sequenceVersion="2" change="c.807del">
            <Expression>NM_001098209.2:c.807del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001091679.1" sequenceAccession="NP_001091679" sequenceVersion="1" change="p.Met271fs">
            <Expression>NP_001091679.1:p.Met271fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001098210.2" sequenceAccession="NM_001098210" sequenceVersion="2" change="c.807del">
            <Expression>NM_001098210.2:c.807del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001091680.1" sequenceAccession="NP_001091680" sequenceVersion="1" change="p.Met271fs">
            <Expression>NP_001091680.1:p.Met271fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330729.2" sequenceAccession="NM_001330729" sequenceVersion="2" change="c.786del">
            <Expression>NM_001330729.2:c.786del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317658.1" sequenceAccession="NP_001317658" sequenceVersion="1" change="p.Met264fs">
            <Expression>NP_001317658.1:p.Met264fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001904.4" sequenceAccession="NM_001904" sequenceVersion="4" change="c.807del" MANESelect="true">
            <Expression>NM_001904.4:c.807del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001895.1" sequenceAccession="NP_001895" sequenceVersion="1" change="p.Met271fs">
            <Expression>NP_001895.1:p.Met271fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1108" sequenceAccession="LRG_1108">
            <Expression>LRG_1108:g.31282del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1108t1" sequenceAccession="LRG_1108t1">
            <Expression>LRG_1108t1:c.807del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1108p1" sequenceAccession="LRG_1108p1" change="p.Met271fs">
            <Expression>LRG_1108p1:p.Met271fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2078160286" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001904.4(CTNNB1):c.807del (p.Met271fs) AND Severe intellectual disability-progressive spastic diplegia syndrome" Accession="RCV001195546" Version="8">
        <ClassifiedConditionList TraitSetID="9236">
          <ClassifiedCondition DB="MedGen" ID="C3554449">Severe intellectual disability-progressive spastic diplegia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-05-02" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-02" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-07-04" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9236" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17594" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS</ElementValue>
                <XRef Type="MIM" ID="615075" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0022" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0023" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0018" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe intellectual disability-progressive spastic diplegia syndrome</ElementValue>
                <XRef ID="MONDO:0014035" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NEDSDV</ElementValue>
                <XRef Type="MIM" ID="615075" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3505" />
                <XRef ID="3505" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">CTNNB1 neurodevelopmental disorder (CTNNB1-NDD) is characterized in all individuals by mild-to-profound cognitive impairment and in up to 39% of reported individuals by exudative vitreoretinopathy, an ophthalmologic finding consistent with familial exudative vitreoretinopathy (FEVR). Other common findings include truncal hypotonia, peripheral spasticity, dystonia, behavior problems, microcephaly, and refractive errors and strabismus. Less common features include intrauterine growth restriction, feeding difficulties, and scoliosis.</Attribute>
                <XRef ID="NBK580527" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35593792</ID>
                <ID Source="BookShelf">NBK580527</ID>
              </Citation>
              <XRef ID="404473" DB="Orphanet" />
              <XRef ID="C3554449" DB="MedGen" />
              <XRef ID="MONDO:0014035" DB="MONDO" />
              <XRef Type="MIM" ID="615075" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2693828" SubmissionDate="2020-05-14" DateLastUpdated="2020-07-04" DateCreated="2020-07-04">
        <ClinVarSubmissionID localKey="99587275|OMIM:615075" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001365931" DateUpdated="2020-07-04" DateCreated="2020-07-04" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-12-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The p.Met271TrpfsX5 variant in CTNNB1 has not been previously reported in individuals with neurodevelopmental disorder with spastic diplegia and visual defects and is absent from large population studies. However, this variant was confirmed to be de novo in an individual with global developmental delay with absent speech, autism spectrum disorder, hypotonia and hypertonia, dental abnormalities, and esotropia by the Broad Institute Rare Genomes Project. This variant is predicted to cause a frameshift, which alters the proteinâ€™s amino acid sequence beginning at position 271 and is predicted to lead to a truncated or absent protein. Heterozygous loss of function of the CTNNB1 gene is an established disease mechanism in individuals with neurodevelopmental disorder with spastic diplegia and visual defects. In summary, this variant meets criteria to be classified as pathogenic for neurodevelopmental disorder with spastic diplegia and visual defects in an autosomal dominant manner based upon de novo occurrence, its absence from the general population, and its predicted impact on the protein. ACMG/AMP Criteria applied: PS2, PM2, PVS1.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTNNB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.41267223delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615075" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7448406</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7332467" SubmissionDate="2023-11-09" DateLastUpdated="2023-11-11" DateCreated="2023-05-06">
        <ClinVarSubmissionID localKey="853db0ba-c3b1-441d-84e7-503c1f8d5d37" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003922193" DateUpdated="2023-11-11" DateCreated="2023-05-06" Type="SCV" Version="2" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The heterozygous p.Met271TrpfsTer5 variant in CTNNB1 was identified by our study in one individual with absent speech, autism spectrum disorder, developmental delay, hypotonia and hypertonia, dental anomalies, esotropia (Broad Institute Rare Genomes Project). Trio genome analysis showed this variant to be de novo. The p.Met271TrpfsTer5 variant in CTNNB1 has not been previously reported in the literature in individuals with neurodevelopmental disorder with spastic diplegia and visual defects. This variant has also been reported in ClinVar (Variation ID: 930112) and has been interpreted as pathogenic by Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine. This variant was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein‚Äôs amino acid sequence beginning at position 271 and leads to a premature termination codon 5 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Heterozygous loss of function of the CTNNB1 gene is an established disease mechanism in autosomal dominant neurodevelopmental disorder with spastic diplegia and visual defects. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant neurodevelopmental disorder with spastic diplegia and visual defects. ACMG/AMP Criteria applied: PVS1, PS2_Supporting, PM2_Supporting (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTNNB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001904.4(CTNNB1):c.807del</Name>
            <Name>p.Met271fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.12:g.41225732del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0014035" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13232620</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7332467" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0014035" MappingRef="MONDO">
        <MedGen CUI="C3554449" Name="Severe intellectual disability-progressive spastic diplegia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2693828" TraitType="Disease" MappingType="XRef" MappingValue="615075" MappingRef="OMIM">
        <MedGen CUI="C3554449" Name="Severe intellectual disability-progressive spastic diplegia syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

